Marksans Pharma Limited (MARKSANS) stock price gains 8% intraday, breaks out from its 6-month resistance trendline. Current price at ₹303.85.
Marksans Pharma Limited (MARKSANS) stock gains 6% intraday to ₹261.7, showing a bounce despite the 6M trendline status being in breakdown. Full details inside.
Marksans Pharma Limited (NSE: MARKSANS) drops 5% intraday to ₹245.45, breaking below support in the Healthcare sector's Drug Manufacturers - General segment.
Marksans Pharma Limited (MARKSANS) stock breaks out, gaining 5% intraday to ₹277.5, clearing its 6M resistance trendline..
Marksans Pharma Ltd (MARKSANS) acquires ABCnow GmbH for €892,384 to enhance its European market presence and distribution network.
Marksans Pharma Limited (NSE: MARKSANS) to acquire 100% of QliniQ B.V., enhancing its presence in European markets.
Marksans Pharma Limited (MARKSANS) reported Q4 & FY26 financial results with historic triple: highest revenue, EBITDA & PAT ₹3,000 Cr.
